Segment and Geographical Information (Tables)

9 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

The tables below present segment revenue, operating (loss) income and depreciation and amortization, as follows:

	Three Months Ended						Nine Months Ended
	June 30,						June 30,
(Dollars in thousands)	2018			2017			2018			2017
Revenue:
Medical Device	$	16,701		$	12,778		$	43,527		$	39,260
In Vitro Diagnostics		5,526			5,012			14,771			13,794
Total revenue	$	22,227		$	17,790		$	58,298		$	53,054
Operating (loss) income:
Medical Device	$	(6,193	)	$	1,403		$	(6,351	)	$	6,627
In Vitro Diagnostics		2,176			2,230			6,269			5,922
Total segment operating (loss) income		(4,017	)		3,633			(82	)		12,549
Corporate		(2,233	)		(1,890	)		(6,277	)		(5,861	)
Total operating (loss) income	$	(6,250	)	$	1,743		$	(6,359	)	$	6,688
Depreciation and amortization:
Medical Device	$	1,333		$	1,132		$	3,929		$	3,180
In Vitro Diagnostics		101			103			291			309
Corporate		171			170			491			517
Total depreciation and amortization	$	1,605		$	1,405		$	4,711		$	4,006